Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.

Ansari MA, Irshad M, Agarwal SK, Chosdol K.

Eur J Gastroenterol Hepatol. 2013 Jul;25(7):806-13. doi: 10.1097/MEG.0b013e32835eb9b9.

PMID:
23442416
2.

Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.

Ali A, Nisar M, Idrees M, Rafique S, Iqbal M.

Int J Infect Dis. 2015 May;34:84-9. doi: 10.1016/j.ijid.2015.03.010. Epub 2015 Mar 18.

3.

Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies.

Beld M, Penning M, van Putten M, van den Hoek A, Lukashov V, McMorrow M, Goudsmit J.

J Clin Microbiol. 1998 Oct;36(10):3002-6.

4.

Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan.

Yousaf MZ, Idrees M, Saleem Z, Rehman IU, Ali M.

Virol J. 2011 Jul 26;8:364. doi: 10.1186/1743-422X-8-364.

5.

Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.

Muerhoff AS, Gutierrez R, Kyrk C, Leary T, Schlauder G, Dawson G, Desai SM.

J Med Virol. 2008 Mar;80(3):411-8. doi: 10.1002/jmv.21082.

PMID:
18205228
6.

Significance of IgM anti-HCV core level in chronic hepatitis C.

Papatheodoridis GV, Delladetsima JK, Katsoulidou A, Sypsa V, Albrecht M, Michel G, Hatzakis A, Tassopoulos NC.

J Hepatol. 1997 Jul;27(1):36-41.

PMID:
9252071
7.

Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis.

Reddy AK, Dakshinamurty KV, Lakshmi V.

Indian J Med Microbiol. 2006 Jan;24(1):55-7.

8.

Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.

Valcavi P, Medici MC, Casula F, Arcangeletti MC, De Conto F, Pinardi F, Calderaro A, Chezzi C, Dettori G.

J Med Virol. 2004 Jul;73(3):397-403.

PMID:
15170635
10.

Differences in HCV antibody patterns in haemodialysis patients infected with the same virus isolate.

de Oliveira JM, Rispeter K, Viazov S, Saback FL, Roggendorf M, Yoshida CF.

J Med Virol. 2001 Apr;63(4):265-70.

PMID:
11241456
11.

Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.

Pujol FH, Khudyakov YE, Devesa M, León G, Blitz-Dorfman L, Monsalve F, Lambert SB, Kalinina TY, Liprandi F, Fields HA.

Viral Immunol. 1996;9(2):89-96.

PMID:
8822625
12.

Synonymous mutations in the core gene are linked to unusual serological profile in hepatitis C virus infection.

Budkowska A, Kakkanas A, Nerrienet E, Kalinina O, Maillard P, Horm SV, Dalagiorgou G, Vassilaki N, Georgopoulou U, Martinot M, Sall AA, Mavromara P.

PLoS One. 2011 Jan 6;6(1):e15871. doi: 10.1371/journal.pone.0015871.

13.

Early detection of anti-HCc antibody in acute hepatitis C virus (HCV) by western blot (immunoblot) using a recombinant HCV core protein fragment.

Yeh CT, Han CM, Lo SY, Ou JH, Fan KD, Sheen IS, Chu CM, Liaw YF.

J Clin Microbiol. 1994 Sep;32(9):2235-41.

14.

Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users.

Netski DM, Wang XH, Mehta SH, Nelson K, Celentano D, Thongsawat S, Maneekarn N, Suriyanon V, Jittiwutikorn J, Thomas DL, Ticehurst JR.

J Clin Microbiol. 2004 Apr;42(4):1631-6.

15.
16.

Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.

Neville JA, Prescott LE, Bhattacherjee V, Adams N, Pike I, Rodgers B, El-Zayadi A, Hamid S, Dusheiko GM, Saeed AA, Haydon GH, Simmonds P.

J Clin Microbiol. 1997 Dec;35(12):3062-70.

17.

HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection.

Jolivet-Reynaud C, Dalbon P, Viola F, Yvon S, Paranhos-Baccala G, Piga N, Bridon L, Trabaud MA, Battail N, Sibai G, Jolivet M.

J Med Virol. 1998 Dec;56(4):300-9.

PMID:
9829633
18.

Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors.

Attia MA, Zekri AR, Goudsmit J, Boom R, Khaled HM, Mansour MT, de Wolf F, el-Din HM, Sol CJ.

J Clin Microbiol. 1996 Nov;34(11):2665-9.

19.

IgM antibody response to the hepatitis C virus core protein in intravenous drug users.

Toniutto P, Falleti E, Gasparini V, Fabris C, Tisminetzky SG, Lombardelli T, Pacco P, Satta A, Pirisi M.

Diagn Microbiol Infect Dis. 1999 Feb;33(2):69-73.

PMID:
10091028
20.

Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.

Xiang J, Wünschmann S, George SL, Klinzman D, Schmidt WN, LaBrecque DR, Stapleton JT.

J Med Virol. 2002 Dec;68(4):537-43.

PMID:
12376962
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk